Morton J E, Leyland M J, Vaughan Hudson G, Vaughan Hudson B, Anderson L, Bennett M H, MacLennan K A
Department of Clinical Haematology, East Birmingham Hospital, UK.
Br J Cancer. 1993 Apr;67(4):776-82. doi: 10.1038/bjc.1993.141.
A retrospective analysis was performed upon 175 patients with Non-Hodgkin's Lymphoma involving the gastrointestinal tract and entered into BNLI trials and studies between 1974-1988. Malignant histiocytosis of the intestine (MHI), which was present in 16 patients, was associated with a survival of less than 25% at 18 months, and probably accounted for the poor survival of patients with jejunal involvement. Histopathological evidence of tumour origin from mucosa-associated lymphoid tissue (MALT) was found in 50% of patients with gastric involvement and in 27% of those with intestinal involvement. The overall survival of the series as a whole was 44% at 10 years. Multivariate analysis identified evidence of tumour origin from MALT as the only factor to attain prognostic significance in patients with gastric involvement, and clinical stage and the presence of MHI as the only factors to attain prognostic significance in patients with intestinal involvement. It is suggested that there is a need for a large multicentre prospective study of GIT lymphoma.
对1974年至1988年间参加BNLI试验和研究的175例累及胃肠道的非霍奇金淋巴瘤患者进行了回顾性分析。16例患者存在肠道恶性组织细胞增多症(MHI),其18个月生存率低于25%,可能是空肠受累患者生存率低的原因。50%的胃受累患者和27%的肠受累患者有肿瘤起源于黏膜相关淋巴组织(MALT)的组织病理学证据。该系列患者的10年总生存率为44%。多变量分析确定,肿瘤起源于MALT的证据是胃受累患者中唯一具有预后意义的因素,而临床分期和MHI的存在是肠受累患者中唯一具有预后意义的因素。建议对胃肠道淋巴瘤进行大型多中心前瞻性研究。